Novel therapies for epilepsy in the pipeline. Academic Article uri icon

abstract

  • Despite the availability of many antiepileptic drugs (AEDs) (old and newly developed) and, as recently suggested, their optimization in the treatment of patients with uncontrolled seizures, more than 30% of patients with epilepsy continue to experience seizures and have drug-resistant epilepsy; the management of these patients represents a real challenge for epileptologists and researchers. Resective surgery with the best rates of seizure control is not an option for all of them; therefore, research and discovery of new methods of treating resistant epilepsy are of extreme importance. In this article, we will discuss some innovative approaches, such as P-glycoprotein (P-gp) inhibitors, gene therapy, stem cell therapy, traditional and novel antiepileptic devices, precision medicine, as well as therapeutic advances in epileptic encephalopathy in children; these treatment modalities open up new horizons for the treatment of patients with drug-resistant epilepsy.

published proceedings

  • Epilepsy Behav

altmetric score

  • 6.5

author list (cited authors)

  • Mesraoua, B., Deleu, D., Kullmann, D. M., Shetty, A. K., Boon, P., Perucca, E., Mikati, M. A., & Asadi-Pooya, A. A.

citation count

  • 19

complete list of authors

  • Mesraoua, Boulenouar||Deleu, Dirk||Kullmann, Dimitri M||Shetty, Ashok K||Boon, Paul||Perucca, Emilio||Mikati, Mohamad A||Asadi-Pooya, Ali A

publication date

  • January 2019